rs142059019
Variant summary
Our verdict is Likely benign. Variant got -1 ACMG points: 2P and 3B. PM2BP4_ModerateBP6
The NM_004415.4(DSP):āc.145A>Gā(p.Thr49Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000191 in 1,567,968 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_004415.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -1 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152152Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.00000590 AC: 1AN: 169360Hom.: 0 AF XY: 0.0000110 AC XY: 1AN XY: 90854
GnomAD4 exome AF: 0.00000141 AC: 2AN: 1415816Hom.: 0 Cov.: 32 AF XY: 0.00000143 AC XY: 1AN XY: 700118
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152152Hom.: 0 Cov.: 33 AF XY: 0.0000135 AC XY: 1AN XY: 74336
ClinVar
Submissions by phenotype
not provided Uncertain:1
p.Thr49Ala (ACC>GCC): c.145 A>G in exon 1 of the DSP gene (NM_004415.2). The T49A variant has not been published as a mutation, nor has it been reported as a benign polymorphism to our knowledge. The T49A variant was not observed at a significant frequency in approximately 6400 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. The T49A variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. However, this substitution occurs at a position that is not conserved across species. Additionally, in silico analysis predicts this variant likely does not alter the protein structure/function. No other missense mutations in nearby residues have been reported in association with ARVC.Therefore, based on the currently available information, it is unclear whether this variant is a pathogenic mutation or a rare benign variant. The variant is found in ARVC panel(s). -
Cardiovascular phenotype Uncertain:1
The c.145A>G (p.T49A) alteration is located in exon 1 (coding exon 1) of the DSP gene. This alteration results from a A to G substitution at nucleotide position 145, causing the threonine (T) at amino acid position 49 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
not specified Benign:1
p.Thr49Ala in exon 1 of DSP: This variant is not expected to have clinical signi ficance due to a lack of conservation across species, including mammals. Of note , 3 mammals (lesser Egyptian jerboa, white rhinoceros and hedgehog shrew) have a n alanine (Ala) at this position despite moderate nearby amino acid conservation . In addition, computational prediction tools do not suggest a high likelihood o f impact to the protein. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at